BurchHB, PerrosP, BednarczukT, et al.Management of thyroid eye disease: A consensus statement by the American Thyroid Association and the European Thyroid association. Thyroid, 2022; 32 [Epub ahead of print]; doi: THY-2022-0251.
2.
(No author). Ophthalmic Graves' disease. Brit Med J, 1967; 2:329–330.
3.
MeansJH.Hyperophthalmic Graves' disease. Ann Intern Med, 1945; 23:779–789.
4.
SchlüterA, HorstmannM, Diaz-CanoS, et al.Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy. Clin Exp Immunol, 2018; 191:255–267.
5.
MouritsMP.Historical notes on Graves' disease. In: Graves' Orbitopathy: A Multidisciplinary Approach. (WiersingaWM, KahalyGJ, eds.) Karger: Basel; 2007; pp. 246–253.
6.
Duke-ElderS, MacFaulPA. Orbital involvement in general disease. In: System of Ophthalmology, vol. XVIII, part II. (Duke-ElderS, ed.) Henry Kimpton: London; 1974; pp. 935–968.
7.
KhooDH, EngPH, HoSC, et al.Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: Prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid, 2000; 10:1093–1100; doi: 10.1089/thy.2000.10.1093
8.
BesicN, LuznikZ.Choroidal and orbital metastases from thyroid cancer. Thyroid, 2013; 23:543–551; doi: 10.1089/thy.2012.0021
9.
BartalenaL, KahalyGJ, BaldeschiL, et al.The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol, 2021; 185:G43–G67; doi: 10.1530/EJE-21-0479
10.
WiersingaWM.Combined thyroid eye clinic: The importance of a multidisciplinary health care in patients with Graves' orbitopathy. Pediatr Endocrinol Rev, 2010; 7(Suppl. 2):250–253.
11.
ZlotoO, SagivO, PrielA, et al.Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel. Graefes Arch Clin Exp Ophthalmol, 2021; 259:2009–2015; doi: 10.1007/s00417-021-05103-5
12.
PrinsenCAC, MokkinkLB, BouterLM, et al.COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res, 2018; 27:1147–1157; doi: 10.1007/s11136-018-1798-3
13.
GormanCA, GarrityJA, FatourechiV, et al.A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology, 2001; 108:1523–1534; doi: 10.1016/s0161-64200000(01)00632-7
